BDBM221495 6-{[(1r)-1- cyclobutylethyl]amino}- 8-[(1r,4r)-2-oxa-5- azabicyclo[2.2.1]hept- 5-yl]-7-[4- (trifluoromethyl)benzyl]- 7h-purine-2- carboxylic acid::US9540377, 9.27

SMILES C[C@@H](Nc1nc(nc2nc(N3C[C@H]4C[C@@H]3CO4)n(Cc3ccc(cc3)C(F)(F)F)c12)C(O)=O)C1CCC1

InChI Key InChIKey=DZEBUUOYYMVTDI-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 221495   

TargetE3 ubiquitin-protein ligase Mdm2 [17-125](Human)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 221495BDBM221495(US9540377, 9.27 | 6-{[(1r)-1- cyclobutylethyl]amin...)
Affinity DataIC50: 23.7nMT: 2°CAssay Description:An HDM2 FRET assay was developed to assess the compounds' inhibitory activity towards binding of p53 protein. A truncated version of HDM2 with re...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/26/2018
Entry Details
US Patent